CVS Health stock heads into the open after a modest September 10 gain
Published on 09/11/2026 at 03:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVS Health stock closed at USD 95.38 on the NYSE on September 10, 2026, marking a gain of 0.3% for the session. The shares traded between an intraday low of USD 94.80 and a high of USD 96.59, with the closing level sitting comfortably within that range. Relative to a broadly flat major index close on September 10, 2026, CVS Health stock slightly outperformed the wider market.
September 10, 2026 in numbers
CVS Health Corp. (ISIN US1266501006, NYSE: CVS) saw moderate trading activity on September 10, 2026, as the price moved within a range from roughly USD 94.80 at the low to USD 96.59 at the high before settling at USD 95.38 at 4:00 p.m. Eastern Time. Per NYSE data from major quote services, the percent change of 0.3% reflected a small advance from the prior close while keeping the shares well within their 52-week trading corridor. The closing level near USD 95.38 also maintained the stock’s year-to-date gain compared with its level at the beginning of 2026, when it traded in the high USD 70s.
On the fundamental side, investor attention around the September 10, 2026 session remained influenced by management’s recent comments at the Wells Fargo 21st Annual Healthcare Conference held on September 9, 2026. As Seeking Alpha reported, executives discussed margin recovery and cash flow priorities, setting expectations for earnings power over the next several years. In addition, Investing.com noted that Bernstein raised its price target on CVS Health stock to USD 112 on September 10, 2026, citing a faster turnaround at the Aetna insurance business, which provided a supportive backdrop for the shares.
Today’s drivers and events
Today, September 11, 2026, trading in CVS Health stock will take place against a backdrop of recent strategic commentary and analyst activity rather than a scheduled earnings release. According to the conference transcript published by Seeking Alpha, management emphasized plans to strengthen margins and enhance cash generation in the coming years, themes that are likely to remain in focus ahead of the open. In parallel, the updated Bernstein price target discussed by Investing.com keeps attention on the pace of improvement at the Aetna segment and on valuation expectations for the shares. Broader healthcare sector moves and any fresh commentary arising from this week’s industry conferences may also shape sentiment toward CVS Health stock during today’s session.
